Welcome to our dedicated page for Iqvia Hldgs news (Ticker: IQV), a resource for investors and traders seeking the latest updates and insights on Iqvia Hldgs stock.
IQVIA Holdings Inc. (NYSE: IQV) is frequently in the news as a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. News coverage about IQVIA highlights how the company combines high-quality health data, Healthcare-grade AI®, advanced analytics and technology to support clinical development and commercial decision-making.
On this page, readers can follow IQVIA news related to clinical research initiatives, technology launches and strategic partnerships. Recent announcements include a strategic collaboration with Amazon Web Services, under which AWS has been named IQVIA’s Preferred Agentic Cloud Provider to power a next-generation AI platform. Other news items describe the launch of IQVIA’s Clinical Trial Financial Suite, an AI-enabled platform for managing financial aspects of clinical trials, and partnerships with organizations such as Veeva Systems.
IQVIA news also covers topics such as quarterly financial results, leadership and board changes, awards for site relationships in clinical research and the expansion of clinical research networks. For example, the company reports on its Research & Development Solutions bookings and backlog, as well as its recognition with the WCG Pinnacle Award for Site Relationships in Professionalism and Communication.
Investors, researchers and industry professionals can use this news feed to monitor developments in IQVIA’s clinical research services, healthcare analytics capabilities, AI initiatives and collaborations across the life sciences ecosystem. Regularly reviewing IQVIA news can provide insight into how the company is applying data, analytics and technology to support the development and commercialization of medical treatments.
IQVIA Holdings Inc. (NYSE:IQV) announced that Ron Bruehlman, CFO, will participate in a virtual fireside chat at Citi’s 2022 Virtual Healthcare Conference on Thursday, February 24, 2022, at 11:00 a.m. ET. A live audio webcast will be available on the IQVIA Investor Relations website, with a replay accessible later that day. IQVIA is a global leader in analytics and clinical research services for life sciences, operating in over 100 countries with approximately 79,000 employees, focusing on improving healthcare outcomes through insights and technology.
Summary not available.
Summary not available.
IQVIA Holdings Inc. (NYSE: IQV) will release its fourth-quarter and full-year 2021 financial results on February 15, 2022, before the market opens. The management team will present a conference call at 9:00 a.m. Eastern Time on the same day. Interested participants can register in advance via the Investor Relations website. A replay of the event will be available two hours post conclusion. IQVIA is a leader in analytics and clinical research, supporting healthcare improvements across its operations in over 100 countries.
IQVIA has appointed Sheila A. Stamps to its board of directors, effective immediately. With over 40 years of experience in strategic governance and operational management, Ms. Stamps has held leadership roles in both public and private sectors, including as a senior investment advisor for the New York State Comptroller. She serves on boards of multiple public companies and has a strong background in audit and finance. Following her appointment, IQVIA's board comprises 11 directors, ten of whom are independent.
IQVIA (NYSE:IQV) has appointed Leslie Wims Morris to its board of directors, effective immediately. Wims Morris brings over 25 years of financial services experience, currently serving as Managing Director and Head of Corporate Development at JPMorgan Chase. Her expertise includes managing strategic partnerships and participating in firmwide initiatives. CEO Ari Bousbib expressed confidence that her global experience will add valuable insight to the company. Wims Morris holds an MBA from Harvard and a BA in English from Yale.
Summary not available.
IQVIA (NYSE:IQV) has launched new Research Nursing and Phlebotomy services that enhance patient access and care during clinical trials. These services enable patients to receive professional care at home, improving outcomes and reducing costs. Ronan Brown, global head of Decentralized Trial Solutions, emphasized that this initiative reflects IQVIA's commitment to patient-centric research. The mobile workforce provides flexible support for clinical trials, enhancing patient experiences and protocol compliance while ensuring quality oversight and training. This innovation marks a significant step in decentralizing clinical trials.
Summary not available.
IQVIA (NYSE:IQV) has launched a new module, Grants and Funding Management, within its Orchestrated Customer Engagement (OCE) solutions. This module aims to provide life sciences companies a comprehensive tool to manage their global strategic giving programs, from grant submission to payment processing. The automated system enhances user experience and compliance, helping to streamline workflows and reduce errors. IQVIA continues to leverage its expertise to adapt to evolving market needs, promoting efficiency in funding request management.